RxDoctor Payments Data

Jeffrey Hart, DO

Orthopaedic Surgery · Massapequa, NYNPI 1386801579

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 67.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $1,533 and has fallen 90.9% since, to $139 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NY, where the typical reported total is $4,024.

$2,907in general payments, 2019–2025

Across 48 payments — averaging $60.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$2K
  • Medtronic$202
  • DJO, LLC$154
  • Stryker$132
  • Amgen$104
  • Bioventus LLC$93
  • plus $274 from 7 others

What the payments were for

  • Travel & lodging$1,05936%
  • Food & beverage$1,46951%
  • Education$37913%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,907 in reported general payments places this provider in the 40th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$169,012
Medicare patients
216
Services billed
10,564

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone16$148

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Massapequa

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →